U.S. markets closed

IHH Healthcare Berhad (IHHHF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
1.25500.0000 (0.00%)
At close: 2:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close1.2550
BidN/A x N/A
AskN/A x N/A
Day's Range1.2550 - 1.2550
52 Week Range1.1500 - 1.3500
Avg. Volume63
Market Cap11.023B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateJun 27, 2019
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Bloomberg

    Singapore Startup Raises $27 Million for Remote Consultations

    (Bloomberg) -- Doctor Anywhere, a Singapore startup for remote medical consultations, raised $27 million in funding as the coronavirus pandemic fuels demand for telemedicine services.The latest investors include Square Peg, an Australian venture capital firm; EDBI, a Singapore government investment arm; and IHH Healthcare Bhd., which operates hospitals and other facilities in Southeast Asia and beyond. The fundraising brings the startup’s capital base to more than $40 million.Demand for online medical consultations has surged in recent months as the coronavirus overwhelms traditional hospitals and health-care facilities. In China, where the outbreak first erupted in January, more people than ever turned to online consultations and health services after hospitals struggled to cope with the initial deluge of people seeking treatment.Doctor Anywhere’s revenue and usage has grown by two to three times in recent months, Lim Wai Mun, the company’s founder and chief executive officer, said in a phone interview. The global outbreak has encouraged previously skeptical people to try out telemedicine and -- based on the company’s data -- there’s more than a 50% chance that first-time users will return, he added.“It’s definitely a catalyst to shift the fundamentals in the whole telehealth industry,” Lim said. “Our view is that it is not something that is reactive; there is a change in fundamentals.”Doctor Anywhere serves more than a million users in Thailand and Vietnam and its home base of Singapore, which has experienced a resurgence in Covid-19 cases. People there can download its app to consult a licensed doctor for S$20 ($14), and get medicine delivered to their homes. Since the outbreak, Doctor Anywhere has deployed its platform at ferry terminals around the island, and it’s also provided services to self-quarantined individuals. Lim said he now plans to use the new capital to expand to Malaysia and the Philippines while deepening its presence in existing markets.“EDB seeks to bolster Doctor Anywhere’s journey as it continues to champion the adoption of telemedicine to bring healthcare accessibility and affordability to all patients in Southeast Asia,” said Chu Swee Yeok, CEO of EDBI, the investing arm of the government agency spearheading economic development of Singapore.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.